Skip to main content
. 2022 Nov 11;95(1):e28273. doi: 10.1002/jmv.28273

Table 2.

The prevalence of anti‐SARS‐CoV‐2 IgG antibodies in patients with IgG autoantibodies against ACE2 (n = 17) and without them (n = 1122)

Anti‐SARS‐CoV‐2 Group p Value (Pearson's χ2 test)
IgG antibody ACE2 IgG antibodies No ACE2 IgG antibodies
Anti‐RBD (% of patients) 88.2 76.3 >0.05 (χ2 = 1.3)
Anti‐S2 (% of patients) 82.4 38.7 0.0003 (χ2 = 13.4)
Anti‐N (% of patients) 88.2 65.2 0.04 (χ2 = 3.9)